Page 3 - Simulations Plus Inc News Today

-- Simulations Plus said Thursday that the US Food and Drug Administration has renewed its licenses to the DILIsym software platform. Financial details werent disclosed. The one-year renewal will...

Simulations Plus, Inc. announced that the U.S. FDA has renewed its licenses to the DILIsym software platform. DILIsym is the industry gold standard for quantitative systems toxicology software...

Shares of Simulations Plus, Inc. (NASDAQ:SLP – Get Free Report) gapped up before the market opened on Thursday following a better than expected earnings announcement. The stock had previously closed at $38.46, but opened at $44.91. Simulations Plus shares last traded at $46.28, with a volume of 95,888 shares changing hands. The technology company reported […]

Real-time index price for Nasdaq 100 Index (IUXX), along with buy or sell indicators, analysis, charts, historical performance, news and more

Total revenue of $18.3 million and diluted earnings per share of $0.20 Maintains full-year revenue guidance of $66 to $69 million and EPS guidance of $0.66 to $0.68 ...

Strong Revenue Growth and Dividend Declaration in Q2 Fiscal 2024

Simulations Plus, Inc. ("Simulations Plus"), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today reported financial results for its second quarter fiscal 2024, ended February 29, 2024....

Real-time index price for PHLX Oil Service (OSX), along with buy or sell indicators, analysis, charts, historical performance, news and more

Simulations Plus, Inc. (NASDAQ:SLP – Get Free Report) Director Walter S. Woltosz sold 20,000 shares of the stock in a transaction dated Monday, April 1st. The stock was sold at an average price of $39.94, for a total value of $798,800.00. Following the transaction, the director now owns 3,600,195 shares in the company, valued at […]

Simulations Plus, Inc. , a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced that Shawn O’Connor, chief executive officer,...